Drug Staves Off Graft-vs-Host Disease MedPage Today Stem-cell transplant patients who are at high risk for graft-versus-host disease (GVHD) appear to benefit when a drug used in HIV treatment is added to the standard prophylactic regimen. Drug Reduces Graft-Versus-Host After Stem Cell Transplant Maraviroc reduces incidence of GvHD in blood cancer patients after bone ... HIV Drug May Prevent Bone Marrow Transplant Complication |
